Tuesday, April 21, 2026
wellness India Expo
Home Tags Clinical trials

Tag: Clinical trials

India must assume leadership role in clinical research, says ISCR

Ahead of its 10th annual conference, the Indian Society for clinical research talks about the recent changes in the regulatory environment and highlights the impact of the last two years on our healthcare industry....

Govt notifies new medtech rules, industry bodies give mixed reactions

While the categorization of medical technology as a separate industry has been widely hailed by the industry bodies yet the new medical device rules notified by government has left them unsatisfied

Bharat Biotech’s Zikavac to enter phase-I clinical trials

The company's Zika vaccine has completed pre-clinical studies and is now awaiting the regulator's approval to begin phase-1 trials.....

Top experts discuss pharmacovigilant environment in India

Deliberations at the symposium organized by Indian Society for Clinical Research included the evolving regulatory environment in India with focus...

Sun Pharma achieves breaking results for its Psoriasis drug

The company has achieved primary end point in both Phase-3 studies in patients with moderate-to-severe plaque Psoriasis...

On its way back to revival, Indian clinical research industry awaits...

There used to be a time when India was an instant hit globally for its affordable yet quality expertize in handling clinical trials but then.....

Quintiles, DaVita Clinical Research enter into strategic alliance

DaVita Clinical Research brings to this alliance data-driven trial feasibility expertise, trial sites in Europe and Latin America, its deep.....

Industry welcomes CDSCO’s circular on investigators & sites

The Central Drugs Standard Control Organization's decision reflects the views of most of the stakeholders, mentioned the Indian Society for.......

Quintiles welcomes DCGI’s revised rules on clinical trials

In a statement, one of the leading global players in clinical research has appreciated the move by the Drugs Controller General.....

DCGI revises its 50 bed hospital, 3 clinical trials per investigator...

The Drug Controller General of India has finally decided to revise the earlier move that made maximum 3 trials per investigator....